Bibliografia: Pillole di medicina e farmacologia: Riduzione del rischio dei tumori al seno

Articolo L’altra medicina N. 105 – 05/2021


  1. Independent UK Panel on Breast Cancer Screening. Independent re- view. Lancet 2012; 380:1778.
  2. Gotzsche. Screening mammography. Cochrane Rev 2013;6:CD001877. 3-42. Nella Pillola per medici 150-1/2018 ai numeri corrisponde la bibliografia

3-40. La bibliografia riferita a ciascun numero è riportata nella Pillola per medici 150-151/2018. 

  1. Lauby-Secretan B et al. Body Fatness and Cancer — Viewpoint of the IARC Working Group. NEJM 2016; 375:794.
  2. Bhaskaran K et al. Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5·24 million UK adults. Lancet 2014;384:755.
  3. IARC Handbooks of Cancer Prevention. Weight control and physical activity. IARC, Lyon, 2002.

5’. Protani M et al. Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis. Breast Cancer Res Treat 2010;123:627.

  1. Esposito K et al. Metabolic syndrome and risk of cancer: a systematic review and meta-analysis. Diabetes Care 2012;35:2402.
  2. Berrino F et al. Metabolic syndrome and breast cancer prognosis. Breast Cancer Res Treat 2014. 147:159.
  3. Schutze M et al. Alcohol attributable burden of incidence of cancer in eight European countries based on results from prospective cohort study. BMJ 2011;342:d1584.
  4. Cao Y et al. Light to moderate intake of alcohol, drinking patterns, and risk of cancer: results from two prospective US cohort studies. BMJ 2015;351:h4238.
  5. Liu Y et al. Alcohol intake between menarche and first pregnancy: a prospective study of breast cancer risk. J Natl Cancer Inst 2013;105:1571.
  6. 11. Lippi et al. Meat consumption and cancer risk: a critical review of published meta-analyses. Crit Rev Oncol Hematol 2016;97:1.
  7. 12. Taylor VH et al. Is red meat intake a risk factor for breast cancer among premenopausal women? Breast Cancer Res Treat 2009;117:1.
  8. 13. Namiranian N et al. Risk factors of breast cancer in the Eastern Mediterranean Region: a systematic review and meta-analysis. Asian Pac J Cancer Prev 2014;15:9535.
  9. Alexander DD et al. A review and meta-analysis of red and processed meat consumption and breast cancer. Nutr Res Rev 2010b; 23:349.
  10. Guo J et al. Red and processed meat intake and risk of breast cancer: a meta-analysis of prospective studies. Breast Cancer Res Treat 2015;151:191.
  11. Anderson JJ et al. Red and processed meat consumption and breast cancer:…meta-analysis. Eur J Cancer 2018;90:73.
  12. Farvid MS et al. Dietary protein sources in early adulthood and breast cancer incidence: prospective cohort study. BMJ 2014;348:g3437.
  13. Sieri S et al. Dietary Fat intake and development of specific breast cancer subtypes. JNCI 2014;106:068.
  14. Chlebowski RT et al. Low-Fat Dietary Pattern and Breast Cancer Mortality in the WHI RCT.
  15. Gaudet M et al. Active smoking and breast cancer risk: original cohort data and meta-analysis. JNCI 2013;105:515.
  16. Manson JE et al. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the WHI RTs. JAMA 2013;310:1353.
  17. Reeves GK et al. Hormonal therapy for menopause and breast-cancer risk by histological type: a cohort study and meta-analysis. Lancet Oncology 2006; 7:910-918.
  18. 23. Jones ME et al. Menopausal hormone therapy and breast cancer: what is the true size of the increased risk? Br J Cancer 2016;115:607.
  19. Hicks BM et al. Glucagon-like peptide-1 analogues and risk of breast cancer in women with type 2 diabetes: population based cohort study using the UK Clinical Practice Research Datalink. BMJ 2016;355:i5340.
  20. 25. IARC Monographs. Radiation. Lyon, France – 2012.
  21. Toledo E et al. Mediterranean diet and invasive breast cancer risk among women at high cardiovascular risk in the PREDIMED Trial: A RCT. JAMA Intern Med 2015;175:1752.
  22. van den Brandt PA et al. Mediterranean diet adherence and risk of postmenopausal breast cancer: results of a cohort study and meta-analysis. IJC 2017;140:2220.
  23. Farvid MS et al. Fruit and vegetable consumption in adolescence and early adulthood and risk of breast cancer: population based cohort study. BMJ 2016;353:i2343.
  24. Bradbury KE et al. Fruit, vegetable, and fiber intake in relation to cancer risk: findings from the EPIC. Am J Clin Nutr 2014;100(suppl):394S.
  25. Farvid MS et al. Dietary fiber intake in young adults and breast cancer risk. Pediatrics 2016; 137: e2 0151226.
  26. Wu J et al. Dietary protein sources and incidence of breast cancer: a dose-response meta-analysis of prospective studies. Nutrients 2016; 8,730,doi:10.3390/nu8110730.
  27. Chi F et al. Post-diagnosis soy food intake and breast cancer survival: a meta-analysis of cohort studies. Asian Pac J Cancer Prev. 2013;14:2407.

33. Zhang FF et al. Dietary isoflavone intake and all-cause mortality in breast cancer survivors: The Breast Cancer Family Registry. Cancer 2017;:.

  1. Ding M et al. Association of coffee consumption with total and cause-specific mortality in 3 large prospective cohorts. Circulation. 2015;132:2305.
  2. Sarria B et al. Regularly consuming a green/roasted coffee blend reduces the risk of metabolic syndrome. Eur J Nutr 2016;:.
  3. Moore SC et al. Association of leisure-time physical activity with risk of 26 types of cancer in 1.44 million adults. JAMA Intern Med 2016;176:816.
  4. IARC Handbook of Cancer Prevention. Weight Control and Physical Activity. 6, 2002.
  5. Agency for Healthcare Research and Quality US. Breastfeeding and maternal and infant health outcomes in developed countries. Evidence Report/TA 153, 2007.
  6. Kwan ML et al. Breastfeeding, PAM50 tumor subtype, and breast cancer prognosis and survival. JNCI 2015;107:djv087.
  7. Hastert TA et al. Adherence to WCRF/AICR cancer prevention recommendations and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 2013; 22:1498.
  8. Cuzick J et al. Tamoxifen for prevention of breast cancer: extended longterm follow-up of the IBIS-I breast cancer prevention trial. Lancet Oncol 2015;16:67.